Pooja Mally, MD
Ophthalmic Plastic and Reconstructive Surgery · Duluth, GANPI 1881856813
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $2,351 of the $3,643 with a category attached, or 64.5%. Amgen accounts for 82.0% of it on its own, with 14 other manufacturers making up the rest. Reporting peaked in 2023 at $1,638 and has fallen 63.2% since, to $603 in 2025.
Across 102 payments — averaging $35.72 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$3K
- Tarsus Pharmaceuticals, Inc.$148
- AbbVie$83
- Novartis$81
- Sun Pharmaceutical Industries Inc.$78
- Alcon$72
- plus $193 from 9 others
What the payments were for
- Speaking & faculty fees$1,27535%
- Food & beverage$2,35165%
- Gifts$170%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen(2 entities) | 73 | $2,988 |
| Tarsus Pharmaceuticals, Inc. | 6 | $148 |
| AbbVie | 4 | $83 |
| Novartis | 4 | $81 |
| Sun Pharmaceutical Industries Inc. | 2 | $78 |
| Alcon | 3 | $72 |
| Biotissue Holdings Inc. | 2 | $32 |
| Oyster Point Pharma, Inc. | 1 | $26 |
| Dompe US, Inc. | 1 | $24 |
| Thea Pharma Inc. | 1 | $23 |
| Solta Medical, A Division Of Bausch Health US, LLC | 1 | $21 |
| Johnson & Johnson Vision Care, Inc. | 1 | $18 |
| Carl Zeiss Meditec, Inc. | 1 | $17 |
| Johnson & Johnson Surgical Vision, Inc. | 1 | $16 |
| Galderma Laboratories, L.p. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- TEPEZZA$1,764
How this compares
Too few ophthalmic plastic and reconstructive surgery providers in Georgiato place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Tobramycin-DexamethasoneTobramycin/Dexamethasone | 145 | $6,263 |
| Neomycin-Polymyxin-DexamethNeomycin/Polymyxin B/Dexametha | 173 | $1,796 |
| Loteprednol Etabonate | 14 | $1,601 |
| ErythromycinErythromycin Base | 100 | $895 |
| Doxycycline Hyclate | 11 | $317 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 139 | $285 |
| Methylprednisolone | 52 | $283 |
| Ciprofloxacin Hcl | 12 | $117 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 12 | $94 |
Paid to pharmacies, not to this prescriber.
Other ophthalmic plastic and reconstructive surgery in Duluth
- Junhee LeeDuluth$153
- Brent HayekGainesville$191K
- Daniel HwangAtlanta$105K
- Julia KangJohns Creek$71K
- Adam de la GarzaAtlanta$17K
- Jenna KimSuwanee$2K
- Michael NeimkinAtlanta$2K
- Zhenyang ZhaoAtlanta$742
- Adam WeberKennesaw$706
- Diane WangAtlanta$660
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.